Literature DB >> 3595708

Effect of josamycin on plasma cyclosporine levels.

C Kreft-Jais, E M Billaud, C Gaudry, J Bedrossian.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3595708     DOI： 10.1007/bf00607585

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  3 in total

1.  Possible interaction between cyclosporine and erythromycin.

Authors:  D E Kohan
Journal:  N Engl J Med       Date:  1986-02-13       Impact factor: 91.245

2.  Interaction between cyclosporin and erythromycin in a kidney transplant patient.

Authors:  M Kessler; J Louis; E Renoult; B Vigneron; P Netter
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

3.  Effect of erythromycin on cyclosporine levels.

Authors:  R J Ptachcinski; B J Carpenter; G J Burckart; R Venkataramanan; J T Rosenthal
Journal:  N Engl J Med       Date:  1985-11-28       Impact factor: 91.245
  3 in total
  16 in total

Review 1.  Pharmacokinetic drug interactions with cyclosporin (Part II).

Authors:  G C Yee; T R McGuire
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

Review 2.  Formulary management of macrolide antibiotics.

Authors:  D R Guay
Journal:  Pharmacoeconomics       Date:  1995-12       Impact factor: 4.981

Review 3.  Clinical pharmacokinetic properties of the macrolide antibiotics. Effects of age and various pathophysiological states (Part II).

Authors:  P Periti; T Mazzei; E Mini; A Novelli
Journal:  Clin Pharmacokinet       Date:  1989-05       Impact factor: 6.447

4.  The effects of spiramycin on plasma cyclosporin A concentrations in heart transplant patients.

Authors:  R Guillemain; E Billaud; G Dreyfus; C Amrein; M Kitzis; V A Jebara; C Kreft-Jais
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 5.  Clinically significant drug interactions with cyclosporin. An update.

Authors:  C Campana; M B Regazzi; I Buggia; M Molinaro
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

6.  Spiramycin does not increase plasma cyclosporin concentrations in renal transplant patients.

Authors:  M Kessler; P Netter; M Zerrouki; E Renoult; P Trechot; B Dousset; B Jonon; J M Mur
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

7.  Lack of effect of spiramycin on cyclosporin pharmacokinetics.

Authors:  M Kessler; P Netter; H E Renoul; P Trechot; B Dousset; B Bannwarth
Journal:  Br J Clin Pharmacol       Date:  1990-03       Impact factor: 4.335

Review 8.  The clinical and economic potential of cyclosporin drug interactions.

Authors:  J E Martin; A J Daoud; T J Schroeder; M R First
Journal:  Pharmacoeconomics       Date:  1999-04       Impact factor: 4.981

9.  Lack of effect of spiramycin on cyclosporin pharmacokinetics.

Authors:  L Vernillet; P Bertault-Peres; Y Berland; J Barradas; A Durand; M Olmer
Journal:  Br J Clin Pharmacol       Date:  1989-06       Impact factor: 4.335

10.  Interaction between roxithromycin and cyclosporin in heart transplant patients.

Authors:  E M Billaud; R Guillemain; N Fortineau; M D Kitzis; G Dreyfus; C Amrein; C Kreft-Jaïs; J M Husson; P Chrétien
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.